featured
Disparities in Guideline-Concordant Initial Systemic Treatment in Women With HER2− MBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Breast cancer (Dove Medical Press)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Disparities in Guideline-Concordant Initial Systemic Treatment in Women With HER2-Negative Metastatic Breast Cancer: A SEER-Medicare Analysis
Breast Cancer (Dove Med Press) 2021 Apr 01;13(xx)259-269, A Vyas, M Gabriel, S KurianFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.